Urolog. pro Praxi, 2009; 10(5): 287-293

Transrectal prostate biopsy in diagnosing prostate cancer

MUDr. Kamil Belej, Ph.D., FEBU
Urologické oddělení Ústřední vojenská nemocnice, Praha

Historically, the prostate was evaluated for cancer by simple digital rectal examination, and biopsy to obtain a tissue diagnosis of cancer

was performed blindly. The advent of ultrasound technology offered a new way to evaluate the prostate, and biopsy techniques were

soon developed to incorporate ultrasound guidance. The article reviews transrectal ultrasound-guided biopsy of the prostate in the

diagnosis of prostate cancer. This technique is described as performed according to the current knowledge.

Keywords: sonography, biopsy, prostate, carcinoma.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Belej K. Transrectal prostate biopsy in diagnosing prostate cancer. Urol. praxi. 2009;10(5):287-293.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Amin Mahul, Boccon-Gibod L, Egevad L, et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimen. Scand J Urol Nephrol 2005; 39(3): 20-33. Go to original source... Go to PubMed...
    2. Applewhite JC, Matlaga BR, McCullough DL, Hall. Transrectal ultrasound and biopsy in the early diagnosis of prostate cancer. Cancer Control 2001; 8(2): 141-150. Go to original source... Go to PubMed...
    3. Belej K. Léky ovlivňující koagulaci v urologii. Urolog. pro Praxi 2008; 9(2): 64-68.
    4. Belej K. Transrektální sonografie v diagnostice onemocnění prostaty. Urolog. pro Praxi 2009; 10(1): 363-366.
    5. Benson MC, Whang IS, Pantuck A, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992; 147: 815-816. Go to original source... Go to PubMed...
    6. Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 2008; 54(6): 1270-1286. Go to original source... Go to PubMed...
    7. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000; 163: 158-162. Go to original source... Go to PubMed...
    8. Čermák A, Pacík D. Transrektální ultrazvukem vedené biopsie prostaty. Urol Listy 2007; 5(4): 22-29.
    9. Djavan B. Prostate biopsies and the Vienna nomograms. Eur Urol Suppl 2006; 5: 500-510. Go to original source...
    10. Epstein JI, Allsbrook WCJ, Amin MB, et al. Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005; 29: 1228-1242. Go to original source... Go to PubMed...
    11. Hammerer P, Graefen M, Palisaar J, Huland H. Prostatic biopsy after radiotherapy: When and How. Eur Urol Suppl 2002; 1(6): 83-88. Go to original source...
    12. Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71-75. Go to original source... Go to PubMed...
    13. Jarolím L, Kawaciuk I, Veselý Š, et al. Časná diagnostika biochemické recidivy po radikální prostatektomii a její význam pro adjuvantní léčbu (abstrakt). Vybrané otázky onkologie XI, 74-76.
    14. Kawachi MH, et al. NCCN Guidelines for prostate cancer early detection v. 2.2007. http://www.nccn.org/professionals/physician_gls/PDF/prostate_detection.pdf.
    15. Král M, Študent V, Kurfürstová D, a kol. Gleasonovo skóre v biopsii a po radikální prostatektomii - Změny po konferenci ISUP 2005 a význam pro urologa. Urolog. pro Praxi 2007; 8(4): 173-178.
    16. Lane BR, Zippe CD, Abouassaly R, et al. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy. J Urol 2008; 179: 1746-1750. Go to original source... Go to PubMed...
    17. Peyromaure M, Ravery V, Boccon-Gibod L. Biopsies of the transitional zone: impact on the detection of prostatic cancer and prognostic value. Prog Urol 2002; 12: 8-14. Go to PubMed...
    18. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 2004; 350(22): 2239-2246. Go to original source... Go to PubMed...
    19. Zapatero A, Mínguez R, Nieto S, et al. Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: What can they teach us? Eur Urol 2009; 55(4): 902-910. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.